Third COVID Vaccine Dose Boosts Protection in Solid Tumor Patients

(MedPage Today) -- A third dose of Pfizer's COVID-19 vaccine (BNT162b2; Comirnaty) could offer increased protection for cancer patients on active treatment, a new study suggested, as these patients typically don't produce antibody responses on...